AdaptHealth Corp. (AHCO)

Several events have impacted AdaptHealth Corp.'s stock in the past six months. AdaptHealth reported Q3 2025 revenue exceeding forecasts, while EPS missed expectations, and the company reduced debt, leading to a stock increase. AdaptHealth announced its Q4 and full-year 2024 financial results and provided its financial guidance for fiscal year 2025. S&P Global Ratings upgraded AdaptHealth's senior unsecured debt rating. There has been insider selling activity. AdaptHealth has a consensus rating of "Moderate Buy" from analysts, with a potential upside from its price.

Information regarding the specific demand seasonality for AdaptHealth Corp.'s products and services is available through historical insights on market seasonality, but access to this detailed data typically requires a free account on financial analysis platforms.

AdaptHealth Corp. is a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment (HME), medical supplies, and related services. The company operates within the Medical Equipment, Supplies & Distribution sector and the home health care services industry. AdaptHealth's primary focus areas include Sleep Health, providing sleep therapy equipment; Diabetes Health, offering medical devices for diabetes treatment; Respiratory Health, supplying oxygen and related chronic therapy services; and Wellness at Home, delivering HME devices for chronically ill patients. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.

AdaptHealth Corp. has a significant national presence, serving patients annually in all 50 states through a network of approximately 680 locations across 47 states. In 2022, the company had over 700 locations in 47 states, serving more than 3.9 million patients and making over 36,000 home deliveries per day on average.

AdaptHealth is recognized as a national leader and premier provider of home medical equipment, emphasizing a patient-centered approach. The upgrade of its senior unsecured debt rating by S&P Global Ratings in November 2025 could be seen as a positive financial reputation event. A subsidiary was subject to a False Claims Act investigation regarding billing and reimbursements for ventilators from January 1, 2015, to the present.

AdaptHealth Corp. has significant institutional ownership, with 82.67% of the stock held by institutions including BlackRock, Inc., Oep Capital Advisors, L.p., and Vanguard Group Inc. Insider ownership stands at 1.55%, though other sources indicate higher insider ownership percentages. Everest Hill Group Inc. is the largest individual AdaptHealth shareholder, owning 31.39% of the company.